These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 576809)

  • 21. Transcriptional involvement of protein kinase C-alpha isozyme in amphetamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Eur J Neurosci; 2005 Aug; 22(3):715-23. PubMed ID: 16101753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationships between meta-substituted N-ethylamphetamines and locomotor activity in mice.
    Tessel RE; Woods JH; Counsell RE; Lu M
    J Pharmacol Exp Ther; 1975 Feb; 192(2):310-8. PubMed ID: 1117418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.
    Katsura Y; Zhang X; Homma K; Rice KC; Calderon SN; Rothman RB; Yamamura HI; Davis P; Flippen-Anderson JL; Xu H; Becketts K; Foltz EJ; Porreca F
    J Med Chem; 1997 Aug; 40(18):2936-47. PubMed ID: 9288176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Behavior of blood pressure during chronic effect of phenylalkylamines].
    Kemper F
    Arzneimittelforschung; 1969 Oct; 19(10):1702-4. PubMed ID: 5395371
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenylethyl-substituted pyrimido[2,1-f]purinediones and related compounds: structure-activity relationships as adenosine A(1) and A(2A) receptor ligands.
    Drabczyńska A; Müller CE; Schiedel A; Schumacher B; Karolak-Wojciechowska J; Fruziński A; Zobnina W; Yuzlenko O; Kieć-Kononowicz K
    Bioorg Med Chem; 2007 Nov; 15(22):6956-74. PubMed ID: 17827019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacology of L- and DL-oxyfedrin].
    Hüller H; Amon I; Peters R; Schmidt D
    Pharmazie; 1972 Apr; 27(4):242-5. PubMed ID: 4403335
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical and pharmacological studies of anorectic drugs with phenylpiperazinyl structure.
    Bermann MC; Berthelot P; Bonte JP; Debaert M; Lesieur D; Brunet C; Cazin M; Lesieur I; Luyckx M; Cazin JC
    Arzneimittelforschung; 1982; 32(6):604-10. PubMed ID: 7202364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anorectic and motor activity effects of some 1-benzylcycloalkylamines in the rat.
    Mrongovius RI; Ghosh P; Bolt AG
    Clin Exp Pharmacol Physiol; 1979; 6(1):81-6. PubMed ID: 761429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between anorectic potency and affinity for hypothalamic (+)-amphetamine binding sites of phenylethylamines.
    Blosser JC; Barrantes M; Parker RB
    Eur J Pharmacol; 1987 Jan; 134(1):97-103. PubMed ID: 3556402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative anorectic effects of metaraminol and phenylephrine in rats.
    Yeh SY
    Physiol Behav; 1999 Dec 1-15; 68(1-2):227-34. PubMed ID: 10627085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstration of specific binding sites for [3H]mazindol in rat hypothalamus: correlation with the anorectic properties of phenylethylamines.
    Angel I; Paul SM
    Eur J Pharmacol; 1985 Jul; 113(1):133-4. PubMed ID: 4043206
    [No Abstract]   [Full Text] [Related]  

  • 33. A conformational study of phenethylamine receptor sites. 1. Syntheses of semirigid analogs of -methylamphetamine.
    Smissman EE; Pazdernik TL
    J Med Chem; 1973 Jan; 16(1):14-8. PubMed ID: 4682193
    [No Abstract]   [Full Text] [Related]  

  • 34. ANOREXIGENIC AGENTS: AROMATIC SUBSTITUTED 1-PHENYL-2-PROPYLAMINES.
    HOLLAND GF; BUCK CJ; WEISSMAN A
    J Med Chem; 1963 Sep; 6():519-24. PubMed ID: 14173573
    [No Abstract]   [Full Text] [Related]  

  • 35. Some aryloxyalkylamines, N-arylethylenediamines, and related compounds as anorectic agents.
    Shadbolt RS; Sharpe CJ; Brown GR; Ashford A; Ross JW
    J Med Chem; 1971 Sep; 14(9):836-42. PubMed ID: 5140010
    [No Abstract]   [Full Text] [Related]  

  • 36. Phenethylamine inhibitors of partially purified rat and human pancreatic lipase.
    Comai K; Sullivan AC
    J Pharm Sci; 1982 Apr; 71(4):418-21. PubMed ID: 7086649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of quantitative GC-mass spectrometry to study of pharmacokinetics of amphetamine and phentermine.
    Cho AK; Hodshon BJ; Lindeke B; Miwa GT
    J Pharm Sci; 1973 Sep; 62(9):1491-4. PubMed ID: 4743099
    [No Abstract]   [Full Text] [Related]  

  • 38. N-ALICYCLIC AMPHETAMINES.
    FREIFELDER M
    J Med Chem; 1963 Nov; 6():813. PubMed ID: 14184960
    [No Abstract]   [Full Text] [Related]  

  • 39. [PSYCHOANALEPTIC ACTION OF SOME ANOREXIGENIC PHENYLETHYLAMINE DERIVATIVES].
    BOISSIER JR; SIMON P; FICHELLE J; HERVOUET F
    Therapie; 1965; 20():297-309. PubMed ID: 14326876
    [No Abstract]   [Full Text] [Related]  

  • 40. Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters.
    Clare BW
    J Med Chem; 1990 Feb; 33(2):687-702. PubMed ID: 2299636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.